Novel motif:112: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif112_CGYGYAWT
|novel_motifs_human_sample_pval=11376-118A8_11051;0.704668,11327-117E4_11969;0.345,11473-119C6_11054;0.823571,11474-119C7_12067;0.29369...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:08, 9 September 2013
name: | motif112_CGYGYAWT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0000236 | mitotic prometaphase | 2.199433e-14 |
GO:0022402 | cell cycle process | 1.638689e-10 |
GO:0022403 | cell cycle phase | 1.704789e-10 |
GO:0065003 | macromolecular complex assembly | 3.051985e-10 |
GO:0000278 | mitotic cell cycle | 6.138118e-10 |
GO:0000279 | M phase | 1.018863e-9 |
GO:0008210 | estrogen metabolic process | 5.487582e-9 |
GO:0007051 | spindle organization | 6.600534e-9 |
GO:0021520 | spinal cord motor neuron cell fate specification | 9.166912e-9 |
GO:0000087 | M phase of mitotic cell cycle | 1.023016e-8 |
GO:0035272 | exocrine system development | 3.321233e-8 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 6.912395e-8 |
GO:0030953 | astral microtubule organization | 7.932789e-8 |
GO:0043933 | macromolecular complex subunit organization | 9.245866e-8 |
GO:0007067 | mitosis | 1.033481e-7 |
GO:0051256 | spindle midzone assembly involved in mitosis | 1.089079e-7 |
GO:0034622 | cellular macromolecular complex assembly | 1.522304e-7 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.567556e-7 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 2.062213e-7 |
GO:0009235 | cobalamin metabolic process | 2.103394e-7 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 2.475574e-7 |
GO:0071822 | protein complex subunit organization | 2.673409e-7 |
GO:0007052 | mitotic spindle organization | 3.633446e-7 |
GO:0048285 | organelle fission | 3.705880e-7 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.512561e-7 |
GO:0006461 | protein complex assembly | 4.618270e-7 |
GO:0031017 | exocrine pancreas development | 4.757169e-7 |
GO:0070271 | protein complex biogenesis | 4.913039e-7 |
GO:0001501 | skeletal system development | 5.443319e-7 |
GO:0008209 | androgen metabolic process | 5.492712e-7 |
GO:0046886 | positive regulation of hormone biosynthetic process | 6.612938e-7 |
GO:0016191 | synaptic vesicle uncoating | 7.152992e-7 |
GO:0007049 | cell cycle | 7.478060e-7 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 7.743113e-7 |
GO:0010631 | epithelial cell migration | 7.858490e-7 |
GO:0051365 | cellular response to potassium ion starvation | 8.483838e-7 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 8.617415e-7 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 1.029636e-6 |
GO:0001830 | trophectodermal cell fate commitment | 1.199856e-6 |
GO:0035026 | leading edge cell differentiation | 1.404379e-6 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.479969e-6 |
GO:0019046 | reactivation of latent virus | 1.928983e-6 |
GO:0031055 | chromatin remodeling at centromere | 2.029028e-6 |
GO:0006396 | RNA processing | 2.512215e-6 |
GO:0022618 | ribonucleoprotein complex assembly | 3.170550e-6 |
GO:0071526 | semaphorin-plexin signaling pathway | 3.495285e-6 |
GO:0050853 | B cell receptor signaling pathway | 3.511668e-6 |
GO:0071826 | ribonucleoprotein complex subunit organization | 3.769844e-6 |
GO:0001923 | B-1 B cell differentiation | 4.202551e-6 |
GO:0051261 | protein depolymerization | 4.844839e-6 |
GO:0035129 | post-embryonic hindlimb morphogenesis | 5.048874e-6 |
GO:0034621 | cellular macromolecular complex subunit organization | 5.727601e-6 |
GO:0009650 | UV protection | 6.711889e-6 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 6.798165e-6 |
GO:0009744 | response to sucrose stimulus | 6.976413e-6 |
GO:0046339 | diacylglycerol metabolic process | 7.695087e-6 |
GO:0090130 | tissue migration | 8.860766e-6 |
GO:0016339 | calcium-dependent cell-cell adhesion | 9.266144e-6 |
GO:0045040 | protein import into mitochondrial outer membrane | 9.951039e-6 |
GO:0090307 | spindle assembly involved in mitosis | 1.045661e-5 |
GO:0009437 | carnitine metabolic process | 1.507674e-5 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.654651e-5 |
GO:0051255 | spindle midzone assembly | 1.779873e-5 |
GO:0051260 | protein homooligomerization | 1.837333e-5 |
GO:0006428 | isoleucyl-tRNA aminoacylation | 1.839754e-5 |
GO:0048266 | behavioral response to pain | 1.968378e-5 |
GO:0001732 | formation of translation initiation complex | 2.208430e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.264494e-5 |
GO:0071391 | cellular response to estrogen stimulus | 2.296353e-5 |
GO:0006471 | protein ADP-ribosylation | 2.396910e-5 |
GO:0001649 | osteoblast differentiation | 2.476162e-5 |
GO:0006289 | nucleotide-excision repair | 2.495066e-5 |
GO:0043486 | histone exchange | 2.508739e-5 |
GO:0090231 | regulation of spindle checkpoint | 2.654898e-5 |
GO:0044085 | cellular component biogenesis | 2.836548e-5 |
GO:0006354 | transcription elongation, DNA-dependent | 2.914873e-5 |
GO:0000226 | microtubule cytoskeleton organization | 3.449809e-5 |
GO:0033365 | protein localization to organelle | 3.578824e-5 |
GO:0022607 | cellular component assembly | 3.690834e-5 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.958505e-5 |
GO:0031122 | cytoplasmic microtubule organization | 4.193846e-5 |
GO:0001503 | ossification | 4.423623e-5 |
GO:0002176 | male germ cell proliferation | 4.931769e-5 |
GO:0046885 | regulation of hormone biosynthetic process | 4.998860e-5 |
GO:0022027 | interkinetic nuclear migration | 5.012357e-5 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 5.323479e-5 |
GO:0007606 | sensory perception of chemical stimulus | 5.640823e-5 |
GO:0043044 | ATP-dependent chromatin remodeling | 5.689483e-5 |
GO:0030187 | melatonin biosynthetic process | 5.814497e-5 |
GO:0046856 | phosphatidylinositol dephosphorylation | 6.032393e-5 |
GO:0051298 | centrosome duplication | 6.328898e-5 |
GO:0006397 | mRNA processing | 7.018482e-5 |
GO:0060445 | branching involved in salivary gland morphogenesis | 7.195519e-5 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 7.473503e-5 |
GO:0071514 | genetic imprinting | 7.485121e-5 |
GO:0048665 | neuron fate specification | 7.513294e-5 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 7.634815e-5 |
GO:0001708 | cell fate specification | 8.056701e-5 |
GO:0042026 | protein refolding | 8.322642e-5 |
GO:0090232 | positive regulation of spindle checkpoint | 8.445790e-5 |
GO:0044265 | cellular macromolecule catabolic process | 8.462834e-5 |
GO:0033205 | cell cycle cytokinesis | 8.547319e-5 |
GO:0050930 | induction of positive chemotaxis | 8.675996e-5 |
GO:0070286 | axonemal dynein complex assembly | 9.089551e-5 |
GO:0032472 | Golgi calcium ion transport | 9.089551e-5 |
GO:0032468 | Golgi calcium ion homeostasis | 9.089551e-5 |
GO:0030026 | cellular manganese ion homeostasis | 9.089551e-5 |
GO:0051301 | cell division | 1.019743e-4 |
GO:0016476 | regulation of embryonic cell shape | 1.058714e-4 |
GO:0009112 | nucleobase metabolic process | 1.065031e-4 |
GO:0033327 | Leydig cell differentiation | 1.117302e-4 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 1.214472e-4 |
GO:0021905 | forebrain-midbrain boundary formation | 1.214472e-4 |
GO:0003322 | pancreatic A cell development | 1.214472e-4 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 1.214472e-4 |
GO:0030186 | melatonin metabolic process | 1.252913e-4 |
GO:0032352 | positive regulation of hormone metabolic process | 1.265927e-4 |
GO:0032332 | positive regulation of chondrocyte differentiation | 1.280880e-4 |
GO:0051865 | protein autoubiquitination | 1.283099e-4 |
GO:0071109 | superior temporal gyrus development | 1.290924e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 1.364247e-4 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.379775e-4 |
GO:0090346 | cellular organofluorine metabolic process | 1.430764e-4 |
GO:0043602 | nitrate catabolic process | 1.430764e-4 |
GO:0046210 | nitric oxide catabolic process | 1.430764e-4 |
GO:0051781 | positive regulation of cell division | 1.468339e-4 |
GO:0060119 | inner ear receptor cell development | 1.656647e-4 |
GO:0006363 | termination of RNA polymerase I transcription | 1.668017e-4 |
GO:0021978 | telencephalon regionalization | 1.880123e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.884000e-4 |
GO:0046121 | deoxyribonucleoside catabolic process | 2.057297e-4 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 2.256368e-4 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 2.266493e-4 |
GO:0003350 | pulmonary myocardium development | 2.338428e-4 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 2.355282e-4 |
GO:0007435 | salivary gland morphogenesis | 2.381737e-4 |
GO:0061035 | regulation of cartilage development | 2.406696e-4 |
GO:0021522 | spinal cord motor neuron differentiation | 2.445047e-4 |
GO:0033345 | asparagine catabolic process via L-aspartate | 2.467941e-4 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.497505e-4 |
GO:0048705 | skeletal system morphogenesis | 2.529804e-4 |
GO:0009953 | dorsal/ventral pattern formation | 2.547732e-4 |
GO:0010467 | gene expression | 2.566919e-4 |
GO:0060606 | tube closure | 2.596482e-4 |
GO:0051668 | localization within membrane | 2.618064e-4 |
GO:0070914 | UV-damage excision repair | 2.631292e-4 |
GO:0035284 | brain segmentation | 2.651567e-4 |
GO:0048935 | peripheral nervous system neuron development | 2.764934e-4 |
GO:0032330 | regulation of chondrocyte differentiation | 2.848336e-4 |
GO:0009992 | cellular water homeostasis | 2.851172e-4 |
GO:0010893 | positive regulation of steroid biosynthetic process | 2.940134e-4 |
GO:0006839 | mitochondrial transport | 2.947623e-4 |
GO:0034661 | ncRNA catabolic process | 3.013478e-4 |
GO:0035094 | response to nicotine | 3.017187e-4 |
GO:0001843 | neural tube closure | 3.023906e-4 |
GO:0006412 | translation | 3.069916e-4 |
GO:0009057 | macromolecule catabolic process | 3.126837e-4 |
GO:0002448 | mast cell mediated immunity | 3.316772e-4 |
GO:0008615 | pyridoxine biosynthetic process | 3.326963e-4 |
GO:0032808 | lacrimal gland development | 3.336005e-4 |
GO:0009452 | RNA capping | 3.463022e-4 |
GO:0006607 | NLS-bearing substrate import into nucleus | 3.482054e-4 |
GO:0001667 | ameboidal cell migration | 3.815548e-4 |
GO:0050916 | sensory perception of sweet taste | 3.859649e-4 |
GO:0009264 | deoxyribonucleotide catabolic process | 3.953416e-4 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 4.109684e-4 |
GO:0006353 | transcription termination, DNA-dependent | 4.120405e-4 |
GO:0021532 | neural tube patterning | 4.151352e-4 |
GO:0048839 | inner ear development | 4.570540e-4 |
GO:0045636 | positive regulation of melanocyte differentiation | 4.586374e-4 |
GO:0007431 | salivary gland development | 4.715776e-4 |
GO:0014020 | primary neural tube formation | 4.851338e-4 |
GO:0007608 | sensory perception of smell | 4.878273e-4 |
GO:0070925 | organelle assembly | 4.890937e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 4.891018e-4 |
GO:0009110 | vitamin biosynthetic process | 4.891018e-4 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 5.003683e-4 |
GO:0031645 | negative regulation of neurological system process | 5.128306e-4 |
GO:0050926 | regulation of positive chemotaxis | 5.463514e-4 |
GO:0045669 | positive regulation of osteoblast differentiation | 5.486426e-4 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 5.587248e-4 |
GO:0051225 | spindle assembly | 5.615439e-4 |
GO:0051205 | protein insertion into membrane | 5.615715e-4 |
GO:0060560 | developmental growth involved in morphogenesis | 5.720975e-4 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 5.738022e-4 |
GO:0021987 | cerebral cortex development | 5.782038e-4 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 5.885814e-4 |
GO:0044260 | cellular macromolecule metabolic process | 5.892587e-4 |
GO:0021615 | glossopharyngeal nerve morphogenesis | 5.995782e-4 |
GO:0006413 | translational initiation | 6.133255e-4 |
GO:0060113 | inner ear receptor cell differentiation | 6.146674e-4 |
GO:0051970 | negative regulation of transmission of nerve impulse | 6.196128e-4 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 6.220492e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 6.243255e-4 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 6.307978e-4 |
GO:0022616 | DNA strand elongation | 6.324725e-4 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 6.324725e-4 |
GO:0007342 | fusion of sperm to egg plasma membrane | 6.331451e-4 |
GO:0006370 | mRNA capping | 6.516371e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 6.727776e-4 |
GO:0007422 | peripheral nervous system development | 6.799191e-4 |
GO:0045023 | G0 to G1 transition | 7.278158e-4 |
GO:0010917 | negative regulation of mitochondrial membrane potential | 7.278158e-4 |
GO:0050927 | positive regulation of positive chemotaxis | 7.372204e-4 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 7.654380e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.743387e-4 |
GO:0050805 | negative regulation of synaptic transmission | 7.971439e-4 |
GO:0009648 | photoperiodism | 8.249613e-4 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 8.249613e-4 |
GO:0002076 | osteoblast development | 8.786980e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 8.939572e-4 |
GO:0061303 | cornea development in camera-type eye | 8.948930e-4 |
GO:0009267 | cellular response to starvation | 9.041562e-4 |
GO:0071034 | CUT catabolic process | 9.194181e-4 |
GO:0046113 | nucleobase catabolic process | 9.234126e-4 |
GO:0051325 | interphase | 9.272587e-4 |
GO:0060028 | convergent extension involved in axis elongation | 9.315404e-4 |
GO:0002021 | response to dietary excess | 9.319539e-4 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 9.319904e-4 |
GO:0090304 | nucleic acid metabolic process | 9.599368e-4 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 9.688065e-4 |
GO:0006208 | pyrimidine base catabolic process | 9.891335e-4 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 9.909901e-4 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 9.909901e-4 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 9.909901e-4 |
GO:0042840 | D-glucuronate catabolic process | 9.909901e-4 |
GO:0007371 | ventral midline determination | 9.909901e-4 |
GO:0016071 | mRNA metabolic process | 1.011614e-3 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.042383e-3 |
GO:0032467 | positive regulation of cytokinesis | 1.043659e-3 |
GO:0015889 | cobalamin transport | 1.054521e-3 |
GO:0048755 | branching morphogenesis of a nerve | 1.114756e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 1.117137e-3 |
GO:0021796 | cerebral cortex regionalization | 1.136239e-3 |
GO:0048663 | neuron fate commitment | 1.136487e-3 |
GO:0034199 | activation of protein kinase A activity | 1.138868e-3 |
GO:0048675 | axon extension | 1.247661e-3 |
GO:0003151 | outflow tract morphogenesis | 1.250977e-3 |
GO:0008152 | metabolic process | 1.268680e-3 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 1.270155e-3 |
GO:0006853 | carnitine shuttle | 1.270155e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.273599e-3 |
GO:0046839 | phospholipid dephosphorylation | 1.279302e-3 |
GO:0051329 | interphase of mitotic cell cycle | 1.279714e-3 |
GO:0051302 | regulation of cell division | 1.300862e-3 |
GO:0033081 | regulation of T cell differentiation in thymus | 1.325274e-3 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 1.330521e-3 |
GO:0032971 | regulation of muscle filament sliding | 1.333804e-3 |
GO:0070207 | protein homotrimerization | 1.360360e-3 |
GO:0000387 | spliceosomal snRNP assembly | 1.360456e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 1.360816e-3 |
GO:0031953 | negative regulation of protein autophosphorylation | 1.361393e-3 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 1.363419e-3 |
GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway | 1.416664e-3 |
GO:0006206 | pyrimidine base metabolic process | 1.455792e-3 |
GO:0060592 | mammary gland formation | 1.469597e-3 |
GO:0019852 | L-ascorbic acid metabolic process | 1.496415e-3 |
GO:0045634 | regulation of melanocyte differentiation | 1.526322e-3 |
GO:0001514 | selenocysteine incorporation | 1.556357e-3 |
GO:0009058 | biosynthetic process | 1.557483e-3 |
GO:0071157 | negative regulation of cell cycle arrest | 1.569730e-3 |
GO:0045906 | negative regulation of vasoconstriction | 1.569730e-3 |
GO:0048588 | developmental cell growth | 1.582055e-3 |
GO:0019853 | L-ascorbic acid biosynthetic process | 1.589976e-3 |
GO:0060174 | limb bud formation | 1.615084e-3 |
GO:0007017 | microtubule-based process | 1.640586e-3 |
GO:0002444 | myeloid leukocyte mediated immunity | 1.685486e-3 |
GO:0060594 | mammary gland specification | 1.695905e-3 |
GO:0034754 | cellular hormone metabolic process | 1.716758e-3 |
GO:0019228 | regulation of action potential in neuron | 1.720137e-3 |
GO:0001704 | formation of primary germ layer | 1.743548e-3 |
GO:0048311 | mitochondrion distribution | 1.765371e-3 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.771596e-3 |
GO:0021602 | cranial nerve morphogenesis | 1.773263e-3 |
GO:0046716 | muscle cell homeostasis | 1.815702e-3 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.844863e-3 |
GO:0000090 | mitotic anaphase | 1.857631e-3 |
GO:0050917 | sensory perception of umami taste | 1.864212e-3 |
GO:0001662 | behavioral fear response | 1.887446e-3 |
GO:0021915 | neural tube development | 1.898779e-3 |
GO:0009446 | putrescine biosynthetic process | 1.911876e-3 |
GO:0006382 | adenosine to inosine editing | 1.987455e-3 |
GO:0044237 | cellular metabolic process | 1.991345e-3 |
GO:0001825 | blastocyst formation | 2.003287e-3 |
GO:2000253 | positive regulation of feeding behavior | 2.006104e-3 |
GO:2000507 | positive regulation of energy homeostasis | 2.006104e-3 |
GO:0050906 | detection of stimulus involved in sensory perception | 2.029874e-3 |
GO:0070585 | protein localization in mitochondrion | 2.105220e-3 |
GO:0048087 | positive regulation of developmental pigmentation | 2.110569e-3 |
GO:0006349 | regulation of gene expression by genetic imprinting | 2.157109e-3 |
GO:0000245 | spliceosome assembly | 2.202688e-3 |
GO:0021543 | pallium development | 2.210066e-3 |
GO:0055078 | sodium ion homeostasis | 2.221716e-3 |
GO:0006913 | nucleocytoplasmic transport | 2.292055e-3 |
GO:0030913 | paranodal junction assembly | 2.294586e-3 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 2.294586e-3 |
GO:0000710 | meiotic mismatch repair | 2.294586e-3 |
GO:0002209 | behavioral defense response | 2.325828e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 2.362326e-3 |
GO:0006974 | response to DNA damage stimulus | 2.395520e-3 |
GO:0017038 | protein import | 2.464961e-3 |
GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound | 2.496063e-3 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 2.505857e-3 |
GO:0031023 | microtubule organizing center organization | 2.507195e-3 |
GO:0001553 | luteinization | 2.539357e-3 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 2.555433e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 2.557750e-3 |
GO:0010608 | posttranscriptional regulation of gene expression | 2.589756e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 2.628613e-3 |
GO:0048146 | positive regulation of fibroblast proliferation | 2.644538e-3 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 2.713337e-3 |
GO:0032288 | myelin assembly | 2.716229e-3 |
GO:0002378 | immunoglobulin biosynthetic process | 2.767072e-3 |
GO:0000725 | recombinational repair | 2.813431e-3 |
GO:0016075 | rRNA catabolic process | 2.818809e-3 |
GO:0048496 | maintenance of organ identity | 2.818809e-3 |
GO:0050434 | positive regulation of viral transcription | 2.820825e-3 |
GO:0048265 | response to pain | 2.848653e-3 |
GO:0034504 | protein localization to nucleus | 2.897436e-3 |
GO:0015879 | carnitine transport | 2.905578e-3 |
GO:0031016 | pancreas development | 2.922393e-3 |
GO:0010907 | positive regulation of glucose metabolic process | 2.926505e-3 |
GO:0042490 | mechanoreceptor differentiation | 2.955151e-3 |
GO:0006446 | regulation of translational initiation | 2.962050e-3 |
GO:0045940 | positive regulation of steroid metabolic process | 2.977415e-3 |
GO:0002051 | osteoblast fate commitment | 2.996148e-3 |
GO:0000022 | mitotic spindle elongation | 2.996148e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 2.998091e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 3.026926e-3 |
GO:0031123 | RNA 3'-end processing | 3.039341e-3 |
GO:0034660 | ncRNA metabolic process | 3.052871e-3 |
GO:0031018 | endocrine pancreas development | 3.055689e-3 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.072327e-3 |
GO:0045667 | regulation of osteoblast differentiation | 3.094392e-3 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 3.110311e-3 |
GO:0007019 | microtubule depolymerization | 3.125977e-3 |
GO:0051647 | nucleus localization | 3.137530e-3 |
GO:0006308 | DNA catabolic process | 3.189444e-3 |
GO:0043170 | macromolecule metabolic process | 3.197041e-3 |
GO:0090251 | protein localization involved in establishment of planar polarity | 3.198214e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 3.227707e-3 |
GO:0042780 | tRNA 3'-end processing | 3.227736e-3 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 3.227736e-3 |
GO:0010571 | positive regulation of DNA replication involved in S phase | 3.227736e-3 |
GO:0000281 | cytokinesis after mitosis | 3.341440e-3 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 3.356361e-3 |
GO:0051169 | nuclear transport | 3.382234e-3 |
GO:0050913 | sensory perception of bitter taste | 3.385924e-3 |
GO:0035499 | carnosine biosynthetic process | 3.444040e-3 |
GO:0060668 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling | 3.444040e-3 |
GO:0008380 | RNA splicing | 3.486940e-3 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 3.494814e-3 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 3.494814e-3 |
GO:0007043 | cell-cell junction assembly | 3.500342e-3 |
GO:0043623 | cellular protein complex assembly | 3.559935e-3 |
GO:0033683 | nucleotide-excision repair, DNA incision | 3.561081e-3 |
GO:0003096 | renal sodium ion transport | 3.561081e-3 |
GO:2000505 | regulation of energy homeostasis | 3.584938e-3 |
GO:0021846 | cell proliferation in forebrain | 3.589619e-3 |
GO:0015872 | dopamine transport | 3.617311e-3 |
GO:0042596 | fear response | 3.663139e-3 |
GO:0043103 | hypoxanthine salvage | 3.762146e-3 |
GO:0071205 | protein localization to juxtaparanode region of axon | 3.762146e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 3.762146e-3 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 3.762146e-3 |
GO:0006473 | protein acetylation | 3.773919e-3 |
GO:0060348 | bone development | 3.783249e-3 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 3.823406e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 3.867116e-3 |
GO:0006517 | protein deglycosylation | 3.928666e-3 |
GO:0007600 | sensory perception | 4.017197e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.175265e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 4.196937e-3 |
GO:0006435 | threonyl-tRNA aminoacylation | 4.222609e-3 |
GO:0006290 | pyrimidine dimer repair | 4.222609e-3 |
GO:0006772 | thiamine metabolic process | 4.275808e-3 |
GO:0032465 | regulation of cytokinesis | 4.278198e-3 |
GO:0042074 | cell migration involved in gastrulation | 4.319367e-3 |
GO:0009163 | nucleoside biosynthetic process | 4.346107e-3 |
GO:0001508 | regulation of action potential | 4.370280e-3 |
GO:0030104 | water homeostasis | 4.374410e-3 |
GO:0033555 | multicellular organismal response to stress | 4.445347e-3 |
GO:0051303 | establishment of chromosome localization | 4.484994e-3 |
GO:0030282 | bone mineralization | 4.528203e-3 |
GO:0060523 | prostate epithelial cord elongation | 4.586373e-3 |
GO:0030163 | protein catabolic process | 4.595715e-3 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 4.635576e-3 |
GO:0016072 | rRNA metabolic process | 4.693571e-3 |
GO:0000093 | mitotic telophase | 4.725223e-3 |
GO:0010738 | regulation of protein kinase A signaling cascade | 4.735888e-3 |
GO:2001108 | positive regulation of Rho guanyl-nucleotide exchange factor activity | 4.770995e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 4.770995e-3 |
GO:0044249 | cellular biosynthetic process | 4.808303e-3 |
GO:0006422 | aspartyl-tRNA aminoacylation | 4.848233e-3 |
GO:0071842 | cellular component organization at cellular level | 4.884495e-3 |
GO:0006626 | protein targeting to mitochondrion | 4.941933e-3 |
GO:0006154 | adenosine catabolic process | 4.990381e-3 |
GO:0046103 | inosine biosynthetic process | 4.990381e-3 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 5.047260e-3 |
GO:0031342 | negative regulation of cell killing | 5.058474e-3 |
GO:0006401 | RNA catabolic process | 5.066567e-3 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 5.116028e-3 |
GO:0031647 | regulation of protein stability | 5.173744e-3 |
GO:0030030 | cell projection organization | 5.221260e-3 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 5.272162e-3 |
GO:0006334 | nucleosome assembly | 5.287046e-3 |
GO:0030854 | positive regulation of granulocyte differentiation | 5.346266e-3 |
GO:0045026 | plasma membrane fusion | 5.384343e-3 |
GO:0015886 | heme transport | 5.399183e-3 |
GO:0065004 | protein-DNA complex assembly | 5.417376e-3 |
GO:0006312 | mitotic recombination | 5.537074e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 5.563635e-3 |
GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 5.620183e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 5.649372e-3 |
GO:0021957 | corticospinal tract morphogenesis | 5.649372e-3 |
GO:0006475 | internal protein amino acid acetylation | 5.695578e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 5.718784e-3 |
GO:0006222 | UMP biosynthetic process | 5.792315e-3 |
GO:0060003 | copper ion export | 5.804269e-3 |
GO:0015677 | copper ion import | 5.804269e-3 |
GO:0008295 | spermidine biosynthetic process | 5.804269e-3 |
GO:0043525 | positive regulation of neuron apoptosis | 5.820684e-3 |
GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 5.849362e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 5.866675e-3 |
GO:0035166 | post-embryonic hemopoiesis | 5.866675e-3 |
GO:0072104 | glomerular capillary formation | 5.883426e-3 |
GO:0060349 | bone morphogenesis | 5.929365e-3 |
GO:0043583 | ear development | 5.980133e-3 |
GO:0000089 | mitotic metaphase | 6.055168e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 6.055168e-3 |
GO:0071844 | cellular component assembly at cellular level | 6.146226e-3 |
GO:0032319 | regulation of Rho GTPase activity | 6.218846e-3 |
GO:0045880 | positive regulation of smoothened signaling pathway | 6.253787e-3 |
GO:0030852 | regulation of granulocyte differentiation | 6.274496e-3 |
GO:0006996 | organelle organization | 6.415904e-3 |
GO:0045759 | negative regulation of action potential | 6.478116e-3 |
GO:0019254 | carnitine metabolic process, CoA-linked | 6.478116e-3 |
GO:0051322 | anaphase | 6.484945e-3 |
GO:0000027 | ribosomal large subunit assembly | 6.529321e-3 |
GO:0051297 | centrosome organization | 6.541680e-3 |
GO:0040001 | establishment of mitotic spindle localization | 6.918393e-3 |
GO:0009414 | response to water deprivation | 6.952869e-3 |
GO:2000273 | positive regulation of receptor activity | 7.013085e-3 |
GO:0010165 | response to X-ray | 7.071337e-3 |
GO:0060350 | endochondral bone morphogenesis | 7.196862e-3 |
GO:0035646 | endosome to melanosome transport | 7.211586e-3 |
GO:0001920 | negative regulation of receptor recycling | 7.211586e-3 |
GO:0033262 | regulation of DNA replication involved in S phase | 7.211586e-3 |
GO:0060259 | regulation of feeding behavior | 7.242796e-3 |
GO:0001841 | neural tube formation | 7.246672e-3 |
GO:0016049 | cell growth | 7.316205e-3 |
GO:0016553 | base conversion or substitution editing | 7.541029e-3 |
GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning | 7.541682e-3 |
GO:0010906 | regulation of glucose metabolic process | 7.910026e-3 |
GO:0051641 | cellular localization | 7.910339e-3 |
GO:0042819 | vitamin B6 biosynthetic process | 7.956745e-3 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 7.956745e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 7.983211e-3 |
GO:0021636 | trigeminal nerve morphogenesis | 8.232903e-3 |
GO:0051457 | maintenance of protein location in nucleus | 8.266707e-3 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.416481e-3 |
GO:0061072 | iris morphogenesis | 8.446256e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 8.479499e-3 |
GO:0002384 | hepatic immune response | 8.479499e-3 |
GO:0051293 | establishment of spindle localization | 8.548738e-3 |
GO:0060737 | prostate gland morphogenetic growth | 8.640104e-3 |
GO:0032350 | regulation of hormone metabolic process | 8.742593e-3 |
GO:0007006 | mitochondrial membrane organization | 8.893296e-3 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 8.971188e-3 |
GO:0021513 | spinal cord dorsal/ventral patterning | 8.983310e-3 |
GO:0021955 | central nervous system neuron axonogenesis | 8.994736e-3 |
GO:0006633 | fatty acid biosynthetic process | 8.997794e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 9.025341e-3 |
GO:0046111 | xanthine biosynthetic process | 9.048200e-3 |
GO:0060407 | negative regulation of penile erection | 9.048200e-3 |
GO:0060169 | negative regulation of adenosine receptor signaling pathway | 9.048200e-3 |
GO:0010825 | positive regulation of centrosome duplication | 9.048200e-3 |
GO:0002314 | germinal center B cell differentiation | 9.048200e-3 |
GO:0006157 | deoxyadenosine catabolic process | 9.048200e-3 |
GO:0046061 | dATP catabolic process | 9.048200e-3 |
GO:0007010 | cytoskeleton organization | 9.084844e-3 |
GO:0043543 | protein acylation | 9.280925e-3 |
GO:0016264 | gap junction assembly | 9.296363e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 9.380778e-3 |
GO:0010587 | miRNA catabolic process | 9.430010e-3 |
GO:0002052 | positive regulation of neuroblast proliferation | 9.485793e-3 |
GO:0060648 | mammary gland bud morphogenesis | 9.537310e-3 |
GO:0002158 | osteoclast proliferation | 9.619344e-3 |
GO:0046058 | cAMP metabolic process | 9.648875e-3 |
GO:0009950 | dorsal/ventral axis specification | 9.916737e-3 |
GO:0044257 | cellular protein catabolic process | 1.001387e-2 |
GO:0003208 | cardiac ventricle morphogenesis | 1.002452e-2 |
GO:0003401 | axis elongation | 1.008424e-2 |
GO:0006281 | DNA repair | 1.014033e-2 |
GO:0046129 | purine ribonucleoside biosynthetic process | 1.015395e-2 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.018603e-2 |
GO:0007628 | adult walking behavior | 1.021579e-2 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.026673e-2 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.034561e-2 |
GO:0006259 | DNA metabolic process | 1.035967e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0044237 | cellular metabolic process | 1.055696e-13 |
GO:0001830 | trophectodermal cell fate commitment | 7.170232e-11 |
GO:0021903 | rostrocaudal neural tube patterning | 9.713837e-11 |
GO:0016191 | synaptic vesicle uncoating | 2.147047e-10 |
GO:0001708 | cell fate specification | 2.972389e-10 |
GO:0010960 | magnesium ion homeostasis | 6.151222e-10 |
GO:0003207 | cardiac chamber formation | 6.736826e-10 |
GO:0003211 | cardiac ventricle formation | 1.180541e-9 |
GO:0044260 | cellular macromolecule metabolic process | 1.881247e-9 |
GO:0014033 | neural crest cell differentiation | 2.171736e-9 |
GO:0048562 | embryonic organ morphogenesis | 2.505350e-9 |
GO:0045165 | cell fate commitment | 3.211179e-9 |
GO:0060485 | mesenchyme development | 6.795951e-9 |
GO:0015074 | DNA integration | 7.310266e-9 |
GO:0021522 | spinal cord motor neuron differentiation | 8.867652e-9 |
GO:0060173 | limb development | 9.716247e-9 |
GO:0009950 | dorsal/ventral axis specification | 1.060436e-8 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.116972e-8 |
GO:0048483 | autonomic nervous system development | 1.177745e-8 |
GO:0048705 | skeletal system morphogenesis | 1.411125e-8 |
GO:0072539 | T-helper 17 cell differentiation | 1.471974e-8 |
GO:0021532 | neural tube patterning | 1.679251e-8 |
GO:0001501 | skeletal system development | 1.827234e-8 |
GO:0048485 | sympathetic nervous system development | 1.829291e-8 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 2.439795e-8 |
GO:0001649 | osteoblast differentiation | 2.475220e-8 |
GO:0048762 | mesenchymal cell differentiation | 3.858402e-8 |
GO:0006685 | sphingomyelin catabolic process | 4.075981e-8 |
GO:0014898 | cardiac muscle hypertrophy in response to stress | 4.994055e-8 |
GO:0090304 | nucleic acid metabolic process | 5.356142e-8 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.182252e-8 |
GO:0046452 | dihydrofolate metabolic process | 6.859679e-8 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.118622e-7 |
GO:0030182 | neuron differentiation | 1.169722e-7 |
GO:0048242 | epinephrine secretion | 1.280060e-7 |
GO:0060025 | regulation of synaptic activity | 1.332409e-7 |
GO:2000987 | positive regulation of behavioral fear response | 1.332409e-7 |
GO:0003185 | sinoatrial valve morphogenesis | 1.332409e-7 |
GO:0003138 | primary heart field specification | 1.332409e-7 |
GO:0035984 | cellular response to trichostatin A | 1.332409e-7 |
GO:0071864 | positive regulation of cell proliferation in bone marrow | 1.431936e-7 |
GO:0035136 | forelimb morphogenesis | 1.492055e-7 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 1.538773e-7 |
GO:0000279 | M phase | 1.752431e-7 |
GO:0044238 | primary metabolic process | 1.913322e-7 |
GO:0035108 | limb morphogenesis | 2.439671e-7 |
GO:0003170 | heart valve development | 2.485435e-7 |
GO:0003007 | heart morphogenesis | 2.838891e-7 |
GO:0045652 | regulation of megakaryocyte differentiation | 3.060745e-7 |
GO:2000111 | positive regulation of macrophage apoptosis | 3.421528e-7 |
GO:0003179 | heart valve morphogenesis | 3.488996e-7 |
GO:0021520 | spinal cord motor neuron cell fate specification | 3.640007e-7 |
GO:0006807 | nitrogen compound metabolic process | 4.288797e-7 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 4.627703e-7 |
GO:0021905 | forebrain-midbrain boundary formation | 4.627703e-7 |
GO:0003322 | pancreatic A cell development | 4.627703e-7 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 4.627703e-7 |
GO:0046475 | glycerophospholipid catabolic process | 4.919951e-7 |
GO:0002052 | positive regulation of neuroblast proliferation | 4.967889e-7 |
GO:0045885 | positive regulation of survival gene product expression | 5.617181e-7 |
GO:0060563 | neuroepithelial cell differentiation | 7.720725e-7 |
GO:0071559 | response to transforming growth factor beta stimulus | 8.084510e-7 |
GO:0006414 | translational elongation | 8.174065e-7 |
GO:0009953 | dorsal/ventral pattern formation | 8.279999e-7 |
GO:0014009 | glial cell proliferation | 9.048942e-7 |
GO:0003300 | cardiac muscle hypertrophy | 9.133427e-7 |
GO:0048703 | embryonic viscerocranium morphogenesis | 9.181873e-7 |
GO:0003151 | outflow tract morphogenesis | 9.672749e-7 |
GO:0048598 | embryonic morphogenesis | 1.005903e-6 |
GO:0008152 | metabolic process | 1.025184e-6 |
GO:0021515 | cell differentiation in spinal cord | 1.137975e-6 |
GO:0071380 | cellular response to prostaglandin E stimulus | 1.308911e-6 |
GO:0072358 | cardiovascular system development | 1.320915e-6 |
GO:0060349 | bone morphogenesis | 1.388860e-6 |
GO:0035426 | extracellular matrix-cell signaling | 1.643701e-6 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.677141e-6 |
GO:0055075 | potassium ion homeostasis | 1.697690e-6 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.704182e-6 |
GO:2000822 | regulation of behavioral fear response | 1.781370e-6 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1.832685e-6 |
GO:0006683 | galactosylceramide catabolic process | 1.858824e-6 |
GO:0072523 | purine-containing compound catabolic process | 1.865302e-6 |
GO:0006195 | purine nucleotide catabolic process | 1.924311e-6 |
GO:0009058 | biosynthetic process | 1.931767e-6 |
GO:0001947 | heart looping | 2.051879e-6 |
GO:0003357 | noradrenergic neuron differentiation | 2.179929e-6 |
GO:0060070 | canonical Wnt receptor signaling pathway | 2.229938e-6 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 2.399712e-6 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 2.409022e-6 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.632035e-6 |
GO:0010467 | gene expression | 2.747151e-6 |
GO:0090073 | positive regulation of protein homodimerization activity | 2.775375e-6 |
GO:0021796 | cerebral cortex regionalization | 2.874825e-6 |
GO:0009887 | organ morphogenesis | 2.875502e-6 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 3.150385e-6 |
GO:0034498 | early endosome to Golgi transport | 3.177130e-6 |
GO:2000109 | regulation of macrophage apoptosis | 3.202527e-6 |
GO:0003139 | secondary heart field specification | 3.418274e-6 |
GO:2001013 | epithelial cell proliferation involve in renal tubule morphogenesis | 3.687206e-6 |
GO:0072160 | nephron tubule epithelial cell differentiation | 3.687206e-6 |
GO:0060174 | limb bud formation | 3.773350e-6 |
GO:0060914 | heart formation | 3.862116e-6 |
GO:0060536 | cartilage morphogenesis | 4.186432e-6 |
GO:0043496 | regulation of protein homodimerization activity | 4.201324e-6 |
GO:0009059 | macromolecule biosynthetic process | 4.235361e-6 |
GO:0002244 | hemopoietic progenitor cell differentiation | 4.385017e-6 |
GO:0030224 | monocyte differentiation | 4.434910e-6 |
GO:0051261 | protein depolymerization | 4.556770e-6 |
GO:0033091 | positive regulation of immature T cell proliferation | 4.556770e-6 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 4.701822e-6 |
GO:0035910 | ascending aorta morphogenesis | 4.701822e-6 |
GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification | 4.826305e-6 |
GO:0045778 | positive regulation of ossification | 5.053424e-6 |
GO:0007067 | mitosis | 5.228369e-6 |
GO:0070848 | response to growth factor stimulus | 5.277498e-6 |
GO:0071363 | cellular response to growth factor stimulus | 5.290295e-6 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 6.186982e-6 |
GO:0033692 | cellular polysaccharide biosynthetic process | 6.518639e-6 |
GO:0002320 | lymphoid progenitor cell differentiation | 6.729130e-6 |
GO:0021930 | cerebellar granule cell precursor proliferation | 6.869385e-6 |
GO:0044249 | cellular biosynthetic process | 7.029712e-6 |
GO:0009166 | nucleotide catabolic process | 7.117621e-6 |
GO:0010628 | positive regulation of gene expression | 7.190251e-6 |
GO:0070286 | axonemal dynein complex assembly | 7.362272e-6 |
GO:0048854 | brain morphogenesis | 7.954782e-6 |
GO:0042769 | DNA damage response, detection of DNA damage | 8.139163e-6 |
GO:0005978 | glycogen biosynthetic process | 9.012499e-6 |
GO:0000087 | M phase of mitotic cell cycle | 9.087158e-6 |
GO:0071498 | cellular response to fluid shear stress | 9.332351e-6 |
GO:0048285 | organelle fission | 9.433444e-6 |
GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway | 9.493965e-6 |
GO:0007000 | nucleolus organization | 9.713472e-6 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 9.750217e-6 |
GO:0000902 | cell morphogenesis | 1.004186e-5 |
GO:0055078 | sodium ion homeostasis | 1.025829e-5 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 1.173472e-5 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 1.178332e-5 |
GO:0071107 | response to parathyroid hormone stimulus | 1.196075e-5 |
GO:0003310 | pancreatic A cell differentiation | 1.196075e-5 |
GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification | 1.226578e-5 |
GO:0021915 | neural tube development | 1.287604e-5 |
GO:0016070 | RNA metabolic process | 1.347953e-5 |
GO:0007521 | muscle cell fate determination | 1.350493e-5 |
GO:0002328 | pro-B cell differentiation | 1.350493e-5 |
GO:0048858 | cell projection morphogenesis | 1.350588e-5 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 1.366824e-5 |
GO:0055024 | regulation of cardiac muscle tissue development | 1.386871e-5 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 1.399503e-5 |
GO:0021978 | telencephalon regionalization | 1.436654e-5 |
GO:2000271 | positive regulation of fibroblast apoptosis | 1.471305e-5 |
GO:2000270 | negative regulation of fibroblast apoptosis | 1.471305e-5 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 1.471305e-5 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 1.471305e-5 |
GO:0097070 | ductus arteriosus closure | 1.491216e-5 |
GO:0046700 | heterocycle catabolic process | 1.536967e-5 |
GO:0021568 | rhombomere 2 development | 1.634165e-5 |
GO:0044264 | cellular polysaccharide metabolic process | 1.664566e-5 |
GO:0050850 | positive regulation of calcium-mediated signaling | 1.723512e-5 |
GO:0045884 | regulation of survival gene product expression | 1.723512e-5 |
GO:0009987 | cellular process | 1.767219e-5 |
GO:0045666 | positive regulation of neuron differentiation | 1.854451e-5 |
GO:0001667 | ameboidal cell migration | 1.854451e-5 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.871132e-5 |
GO:0046856 | phosphatidylinositol dephosphorylation | 1.906092e-5 |
GO:0003091 | renal water homeostasis | 1.906092e-5 |
GO:0048596 | embryonic camera-type eye morphogenesis | 1.951172e-5 |
GO:0001709 | cell fate determination | 1.958671e-5 |
GO:0010604 | positive regulation of macromolecule metabolic process | 2.066054e-5 |
GO:0014029 | neural crest formation | 2.127610e-5 |
GO:0035909 | aorta morphogenesis | 2.141561e-5 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 2.202439e-5 |
GO:0042093 | T-helper cell differentiation | 2.331183e-5 |
GO:0048048 | embryonic eye morphogenesis | 2.432707e-5 |
GO:0050432 | catecholamine secretion | 2.504719e-5 |
GO:0043170 | macromolecule metabolic process | 2.522820e-5 |
GO:0021510 | spinal cord development | 2.573404e-5 |
GO:0005980 | glycogen catabolic process | 2.586501e-5 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.758695e-5 |
GO:0014031 | mesenchymal cell development | 2.827846e-5 |
GO:0051254 | positive regulation of RNA metabolic process | 2.888433e-5 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 2.983968e-5 |
GO:0051216 | cartilage development | 2.988133e-5 |
GO:0032990 | cell part morphogenesis | 3.011409e-5 |
GO:0021517 | ventral spinal cord development | 3.012392e-5 |
GO:0006298 | mismatch repair | 3.017811e-5 |
GO:0060350 | endochondral bone morphogenesis | 3.126381e-5 |
GO:0048241 | epinephrine transport | 3.260488e-5 |
GO:0055021 | regulation of cardiac muscle tissue growth | 3.307110e-5 |
GO:0031076 | embryonic camera-type eye development | 3.307110e-5 |
GO:0051351 | positive regulation of ligase activity | 3.339664e-5 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 3.365065e-5 |
GO:0003206 | cardiac chamber morphogenesis | 3.417657e-5 |
GO:0030318 | melanocyte differentiation | 3.473183e-5 |
GO:0045065 | cytotoxic T cell differentiation | 3.512672e-5 |
GO:0010694 | positive regulation of alkaline phosphatase activity | 3.745383e-5 |
GO:0072102 | glomerulus morphogenesis | 3.745577e-5 |
GO:0007507 | heart development | 3.867280e-5 |
GO:0031018 | endocrine pancreas development | 3.881391e-5 |
GO:0001568 | blood vessel development | 3.917587e-5 |
GO:0016082 | synaptic vesicle priming | 4.046659e-5 |
GO:0003208 | cardiac ventricle morphogenesis | 4.108647e-5 |
GO:0035810 | positive regulation of urine volume | 4.119393e-5 |
GO:0009143 | nucleoside triphosphate catabolic process | 4.134361e-5 |
GO:0016055 | Wnt receptor signaling pathway | 4.261699e-5 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 4.480979e-5 |
GO:0042472 | inner ear morphogenesis | 4.566492e-5 |
GO:0050931 | pigment cell differentiation | 4.847489e-5 |
GO:2000050 | regulation of non-canonical Wnt receptor signaling pathway | 4.991520e-5 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 5.019333e-5 |
GO:0006681 | galactosylceramide metabolic process | 5.087703e-5 |
GO:0021953 | central nervous system neuron differentiation | 5.149547e-5 |
GO:0034655 | nucleobase-containing compound catabolic process | 5.197593e-5 |
GO:0034435 | cholesterol esterification | 5.381792e-5 |
GO:0031325 | positive regulation of cellular metabolic process | 5.447725e-5 |
GO:0003205 | cardiac chamber development | 5.480519e-5 |
GO:0010092 | specification of organ identity | 5.553309e-5 |
GO:0007267 | cell-cell signaling | 5.563794e-5 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 5.571928e-5 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 5.571928e-5 |
GO:0045922 | negative regulation of fatty acid metabolic process | 5.586664e-5 |
GO:0060297 | regulation of sarcomere organization | 5.673293e-5 |
GO:0000710 | meiotic mismatch repair | 5.763682e-5 |
GO:0019047 | provirus integration | 5.947200e-5 |
GO:0030258 | lipid modification | 6.084349e-5 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6.125275e-5 |
GO:0043624 | cellular protein complex disassembly | 6.272991e-5 |
GO:0003231 | cardiac ventricle development | 6.337717e-5 |
GO:0048066 | developmental pigmentation | 6.390099e-5 |
GO:0005977 | glycogen metabolic process | 6.601161e-5 |
GO:0046826 | negative regulation of protein export from nucleus | 6.696958e-5 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 7.110560e-5 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 7.450353e-5 |
GO:0014896 | muscle hypertrophy | 7.501298e-5 |
GO:0009893 | positive regulation of metabolic process | 7.502358e-5 |
GO:0032463 | negative regulation of protein homooligomerization | 7.522198e-5 |
GO:0032808 | lacrimal gland development | 7.672728e-5 |
GO:0022403 | cell cycle phase | 7.701865e-5 |
GO:0035137 | hindlimb morphogenesis | 7.702565e-5 |
GO:0009154 | purine ribonucleotide catabolic process | 7.961059e-5 |
GO:0003279 | cardiac septum development | 8.057819e-5 |
GO:0042471 | ear morphogenesis | 8.925131e-5 |
GO:0045667 | regulation of osteoblast differentiation | 9.053956e-5 |
GO:0060562 | epithelial tube morphogenesis | 9.124686e-5 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 9.249193e-5 |
GO:0009268 | response to pH | 9.409216e-5 |
GO:0010922 | positive regulation of phosphatase activity | 9.648504e-5 |
GO:0032462 | regulation of protein homooligomerization | 9.802155e-5 |
GO:0019229 | regulation of vasoconstriction | 9.888068e-5 |
GO:0071333 | cellular response to glucose stimulus | 9.934872e-5 |
GO:0007611 | learning or memory | 1.007869e-4 |
GO:0060012 | synaptic transmission, glycinergic | 1.037909e-4 |
GO:0042693 | muscle cell fate commitment | 1.062895e-4 |
GO:0050848 | regulation of calcium-mediated signaling | 1.074353e-4 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.102705e-4 |
GO:0071481 | cellular response to X-ray | 1.107075e-4 |
GO:0043241 | protein complex disassembly | 1.116866e-4 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 1.132445e-4 |
GO:0001692 | histamine metabolic process | 1.132445e-4 |
GO:0015739 | sialic acid transport | 1.154458e-4 |
GO:0044270 | cellular nitrogen compound catabolic process | 1.179426e-4 |
GO:0009261 | ribonucleotide catabolic process | 1.206346e-4 |
GO:0017145 | stem cell division | 1.242604e-4 |
GO:0050890 | cognition | 1.250670e-4 |
GO:0048103 | somatic stem cell division | 1.287502e-4 |
GO:0001503 | ossification | 1.315353e-4 |
GO:0032092 | positive regulation of protein binding | 1.327966e-4 |
GO:0022402 | cell cycle process | 1.341392e-4 |
GO:0048699 | generation of neurons | 1.354157e-4 |
GO:0003289 | atrial septum primum morphogenesis | 1.370100e-4 |
GO:0001944 | vasculature development | 1.371209e-4 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 1.381214e-4 |
GO:0043588 | skin development | 1.387448e-4 |
GO:0045669 | positive regulation of osteoblast differentiation | 1.396224e-4 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.411966e-4 |
GO:0009891 | positive regulation of biosynthetic process | 1.438158e-4 |
GO:0010834 | telomere maintenance via telomere shortening | 1.484235e-4 |
GO:0030149 | sphingolipid catabolic process | 1.501324e-4 |
GO:0061301 | cerebellum vasculature morphogenesis | 1.509394e-4 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 1.569158e-4 |
GO:0021872 | forebrain generation of neurons | 1.576067e-4 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.611598e-4 |
GO:0006163 | purine nucleotide metabolic process | 1.655624e-4 |
GO:0060632 | regulation of microtubule-based movement | 1.692179e-4 |
GO:0002287 | alpha-beta T cell activation involved in immune response | 1.768971e-4 |
GO:0009259 | ribonucleotide metabolic process | 1.774771e-4 |
GO:0001662 | behavioral fear response | 1.810327e-4 |
GO:0035904 | aorta development | 1.818067e-4 |
GO:0021873 | forebrain neuroblast division | 1.871203e-4 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 1.917162e-4 |
GO:0042461 | photoreceptor cell development | 1.917837e-4 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.918695e-4 |
GO:0006112 | energy reserve metabolic process | 1.938303e-4 |
GO:0015804 | neutral amino acid transport | 1.949247e-4 |
GO:0060411 | cardiac septum morphogenesis | 1.990541e-4 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 2.002584e-4 |
GO:0002209 | behavioral defense response | 2.002584e-4 |
GO:0033979 | box H/ACA snoRNA metabolic process | 2.016988e-4 |
GO:0006682 | galactosylceramide biosynthetic process | 2.016988e-4 |
GO:0009653 | anatomical structure morphogenesis | 2.079755e-4 |
GO:0002098 | tRNA wobble uridine modification | 2.084766e-4 |
GO:2000344 | positive regulation of acrosome reaction | 2.184552e-4 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 2.184552e-4 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 2.197306e-4 |
GO:0042596 | fear response | 2.204374e-4 |
GO:0043968 | histone H2A acetylation | 2.232786e-4 |
GO:0048704 | embryonic skeletal system morphogenesis | 2.393279e-4 |
GO:0021778 | oligodendrocyte cell fate specification | 2.401766e-4 |
GO:0010921 | regulation of phosphatase activity | 2.439743e-4 |
GO:0060348 | bone development | 2.446385e-4 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 2.448635e-4 |
GO:0002634 | regulation of germinal center formation | 2.500735e-4 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 2.523145e-4 |
GO:0060420 | regulation of heart growth | 2.545051e-4 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 2.559265e-4 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 2.564510e-4 |
GO:0015844 | monoamine transport | 2.569032e-4 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 2.590303e-4 |
GO:0001755 | neural crest cell migration | 2.590727e-4 |
GO:0003002 | regionalization | 2.592283e-4 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.599629e-4 |
GO:0060271 | cilium morphogenesis | 2.710961e-4 |
GO:0051225 | spindle assembly | 2.744338e-4 |
GO:0035914 | skeletal muscle cell differentiation | 2.843617e-4 |
GO:0045595 | regulation of cell differentiation | 2.898944e-4 |
GO:0021513 | spinal cord dorsal/ventral patterning | 2.904524e-4 |
GO:0001678 | cellular glucose homeostasis | 2.944003e-4 |
GO:0046839 | phospholipid dephosphorylation | 2.984896e-4 |
GO:0050973 | detection of mechanical stimulus involved in equilibrioception | 2.998412e-4 |
GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway | 3.032707e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 3.032907e-4 |
GO:0007049 | cell cycle | 3.052605e-4 |
GO:0006184 | GTP catabolic process | 3.064322e-4 |
GO:0048665 | neuron fate specification | 3.082088e-4 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 3.244839e-4 |
GO:0060668 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling | 3.263036e-4 |
GO:0033005 | positive regulation of mast cell activation | 3.279072e-4 |
GO:0048852 | diencephalon morphogenesis | 3.290679e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 3.412777e-4 |
GO:0048666 | neuron development | 3.425185e-4 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 3.460116e-4 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 3.469606e-4 |
GO:0051340 | regulation of ligase activity | 3.470130e-4 |
GO:0048568 | embryonic organ development | 3.492410e-4 |
GO:0030220 | platelet formation | 3.548196e-4 |
GO:0048645 | organ formation | 3.585352e-4 |
GO:0090307 | spindle assembly involved in mitosis | 3.621626e-4 |
GO:0035809 | regulation of urine volume | 3.642444e-4 |
GO:0015837 | amine transport | 3.716227e-4 |
GO:0030890 | positive regulation of B cell proliferation | 3.744038e-4 |
GO:0071219 | cellular response to molecule of bacterial origin | 3.776320e-4 |
GO:0009150 | purine ribonucleotide metabolic process | 3.798415e-4 |
GO:0071222 | cellular response to lipopolysaccharide | 3.802354e-4 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 3.833970e-4 |
GO:0007228 | positive regulation of hh target transcription factor activity | 3.833970e-4 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 3.843897e-4 |
GO:0001820 | serotonin secretion | 3.873258e-4 |
GO:0033083 | regulation of immature T cell proliferation | 3.880117e-4 |
GO:0021546 | rhombomere development | 3.880117e-4 |
GO:0071322 | cellular response to carbohydrate stimulus | 3.958111e-4 |
GO:0046888 | negative regulation of hormone secretion | 4.078385e-4 |
GO:0060413 | atrial septum morphogenesis | 4.105530e-4 |
GO:0009141 | nucleoside triphosphate metabolic process | 4.171145e-4 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.209260e-4 |
GO:0030501 | positive regulation of bone mineralization | 4.235493e-4 |
GO:0060484 | lung-associated mesenchyme development | 4.299439e-4 |
GO:0007131 | reciprocal meiotic recombination | 4.299439e-4 |
GO:0003283 | atrial septum development | 4.304076e-4 |
GO:0061351 | neural precursor cell proliferation | 4.304301e-4 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 4.398457e-4 |
GO:0072080 | nephron tubule development | 4.402933e-4 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.439850e-4 |
GO:0006351 | transcription, DNA-dependent | 4.704467e-4 |
GO:0031427 | response to methotrexate | 4.727637e-4 |
GO:0044130 | negative regulation of growth of symbiont in host | 4.740669e-4 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 4.761169e-4 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 4.761169e-4 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 4.761169e-4 |
GO:0007371 | ventral midline determination | 4.761169e-4 |
GO:0001841 | neural tube formation | 4.769722e-4 |
GO:0006400 | tRNA modification | 4.884605e-4 |
GO:0032185 | septin cytoskeleton organization | 4.977411e-4 |
GO:0051252 | regulation of RNA metabolic process | 4.982774e-4 |
GO:0071236 | cellular response to antibiotic | 5.003040e-4 |
GO:0070169 | positive regulation of biomineral tissue development | 5.050830e-4 |
GO:0050891 | multicellular organismal water homeostasis | 5.144927e-4 |
GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 5.158636e-4 |
GO:0031396 | regulation of protein ubiquitination | 5.193570e-4 |
GO:0032774 | RNA biosynthetic process | 5.264788e-4 |
GO:0035050 | embryonic heart tube development | 5.429051e-4 |
GO:0045732 | positive regulation of protein catabolic process | 5.481526e-4 |
GO:0042462 | eye photoreceptor cell development | 5.507401e-4 |
GO:0045599 | negative regulation of fat cell differentiation | 5.536062e-4 |
GO:0043570 | maintenance of DNA repeat elements | 5.570858e-4 |
GO:0042178 | xenobiotic catabolic process | 5.570858e-4 |
GO:0007172 | signal complex assembly | 5.775441e-4 |
GO:0048853 | forebrain morphogenesis | 5.802222e-4 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 5.858977e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 5.881274e-4 |
GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 5.954123e-4 |
GO:0051096 | positive regulation of helicase activity | 5.954123e-4 |
GO:0050803 | regulation of synapse structure and activity | 5.974304e-4 |
GO:0008544 | epidermis development | 6.026896e-4 |
GO:0003281 | ventricular septum development | 6.046764e-4 |
GO:0035115 | embryonic forelimb morphogenesis | 6.048852e-4 |
GO:0045844 | positive regulation of striated muscle tissue development | 6.057758e-4 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 6.136216e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 6.256279e-4 |
GO:0050771 | negative regulation of axonogenesis | 6.305359e-4 |
GO:0009117 | nucleotide metabolic process | 6.493111e-4 |
GO:0048663 | neuron fate commitment | 6.514717e-4 |
GO:0007566 | embryo implantation | 6.604269e-4 |
GO:0006545 | glycine biosynthetic process | 6.678043e-4 |
GO:0001550 | ovarian cumulus expansion | 6.678043e-4 |
GO:0030858 | positive regulation of epithelial cell differentiation | 6.780451e-4 |
GO:0007612 | learning | 6.813180e-4 |
GO:0045597 | positive regulation of cell differentiation | 6.922637e-4 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 6.952667e-4 |
GO:0010963 | regulation of L-arginine import | 6.994825e-4 |
GO:0046039 | GTP metabolic process | 6.996636e-4 |
GO:0030910 | olfactory placode formation | 7.009073e-4 |
GO:0014032 | neural crest cell development | 7.309887e-4 |
GO:0032989 | cellular component morphogenesis | 7.344929e-4 |
GO:0043586 | tongue development | 7.366639e-4 |
GO:0021511 | spinal cord patterning | 7.477902e-4 |
GO:0071391 | cellular response to estrogen stimulus | 7.636988e-4 |
GO:0035239 | tube morphogenesis | 7.868029e-4 |
GO:2000678 | negative regulation of transcription regulatory region DNA binding | 8.035553e-4 |
GO:0072044 | collecting duct development | 8.203610e-4 |
GO:0035329 | hippo signaling cascade | 8.286894e-4 |
GO:0061326 | renal tubule development | 8.328679e-4 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.366636e-4 |
GO:0035987 | endodermal cell differentiation | 8.367266e-4 |
GO:0006611 | protein export from nucleus | 8.406256e-4 |
GO:0008284 | positive regulation of cell proliferation | 8.426382e-4 |
GO:0007257 | activation of JUN kinase activity | 8.626499e-4 |
GO:0043589 | skin morphogenesis | 8.664376e-4 |
GO:0060412 | ventricular septum morphogenesis | 8.676715e-4 |
GO:0001711 | endodermal cell fate commitment | 8.878650e-4 |
GO:0072009 | nephron epithelium development | 9.087982e-4 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 9.091225e-4 |
GO:0021879 | forebrain neuron differentiation | 9.185205e-4 |
GO:0048227 | plasma membrane to endosome transport | 9.259725e-4 |
GO:0071423 | malate transmembrane transport | 9.259725e-4 |
GO:0015709 | thiosulfate transport | 9.259725e-4 |
GO:0032474 | otolith morphogenesis | 9.259725e-4 |
GO:0010430 | fatty acid omega-oxidation | 9.259725e-4 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 9.278273e-4 |
GO:0002062 | chondrocyte differentiation | 9.331823e-4 |
GO:0009103 | lipopolysaccharide biosynthetic process | 9.345088e-4 |
GO:0000272 | polysaccharide catabolic process | 9.431137e-4 |
GO:0030030 | cell projection organization | 9.577671e-4 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 9.887658e-4 |
GO:0021506 | anterior neuropore closure | 1.005152e-3 |
GO:0006796 | phosphate-containing compound metabolic process | 1.013390e-3 |
GO:0007254 | JNK cascade | 1.019610e-3 |
GO:0021984 | adenohypophysis development | 1.021873e-3 |
GO:0072521 | purine-containing compound metabolic process | 1.024058e-3 |
GO:0048706 | embryonic skeletal system development | 1.035893e-3 |
GO:0046620 | regulation of organ growth | 1.065648e-3 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 1.074789e-3 |
GO:0043366 | beta selection | 1.076194e-3 |
GO:0051095 | regulation of helicase activity | 1.076194e-3 |
GO:0002286 | T cell activation involved in immune response | 1.098457e-3 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.114268e-3 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 1.115559e-3 |
GO:0007405 | neuroblast proliferation | 1.148725e-3 |
GO:0010468 | regulation of gene expression | 1.149398e-3 |
GO:0009889 | regulation of biosynthetic process | 1.155171e-3 |
GO:0022008 | neurogenesis | 1.181805e-3 |
GO:0016477 | cell migration | 1.228581e-3 |
GO:0050821 | protein stabilization | 1.233955e-3 |
GO:0048839 | inner ear development | 1.239970e-3 |
GO:0046530 | photoreceptor cell differentiation | 1.254887e-3 |
GO:0021514 | ventral spinal cord interneuron differentiation | 1.267413e-3 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 1.267413e-3 |
GO:0033689 | negative regulation of osteoblast proliferation | 1.270877e-3 |
GO:0002009 | morphogenesis of an epithelium | 1.272532e-3 |
GO:0051788 | response to misfolded protein | 1.282935e-3 |
GO:0031398 | positive regulation of protein ubiquitination | 1.302241e-3 |
GO:0031326 | regulation of cellular biosynthetic process | 1.326419e-3 |
GO:0050871 | positive regulation of B cell activation | 1.358579e-3 |
GO:0048812 | neuron projection morphogenesis | 1.359839e-3 |
GO:0030901 | midbrain development | 1.360167e-3 |
GO:0061316 | canonical Wnt receptor signaling pathway involved in heart development | 1.396637e-3 |
GO:0001714 | endodermal cell fate specification | 1.402246e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 1.410086e-3 |
GO:0072006 | nephron development | 1.419803e-3 |
GO:0030032 | lamellipodium assembly | 1.420410e-3 |
GO:0051930 | regulation of sensory perception of pain | 1.429784e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.452436e-3 |
GO:0032204 | regulation of telomere maintenance | 1.459996e-3 |
GO:0021779 | oligodendrocyte cell fate commitment | 1.517538e-3 |
GO:0001101 | response to acid | 1.522366e-3 |
GO:0021523 | somatic motor neuron differentiation | 1.530415e-3 |
GO:0050864 | regulation of B cell activation | 1.563248e-3 |
GO:0034651 | cortisol biosynthetic process | 1.575848e-3 |
GO:0035865 | cellular response to potassium ion | 1.575848e-3 |
GO:0015887 | pantothenate transmembrane transport | 1.575848e-3 |
GO:0015878 | biotin transport | 1.575848e-3 |
GO:0001309 | age-dependent telomere shortening | 1.575848e-3 |